Skip to main content
Caplight Logo









Apollon

Apollon

Private
SeoulHealthcare & Life Scienceshttps://www.apollon.bio/

Last Round

Seed

Apr 19, 2024

Total Funding Raised

$1.7M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Apollon is a medical technology company that develops a needle-free continuous glucose monitoring (CGM) device using Raman spectroscopy to track glucose levels non-invasively.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

continuous glucose monitoringCGMnon-invasive glucose monitorneedle-free glucose monitorRaman spectroscopywearable health techdiabetes caremedtech startupdigital healthoptical sensingbloodless glucose testsmart wearablemetabolic healthmedical devicenon-invasive sensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Apollon Comparables

Compare Apollon with similar companies based on industry and business-model similarity.

Apollon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Afon Technology
87%
RSP Systems A/S
86%
ライトタッチテクノロジー株式会社
82%

Apollon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 19, 2024
SeedNov 1, 2023

Key People

Founding team and executive leadership

Aram Hong

CEO and Co-founder

Founding Team

Miyeon Jue

Chief Technology Officer

Executive Team

Apollon Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 15, 2026

    Grew 16% QoQ, from 37 to 43 employees.

  • Apr 19, 2024

    $1.7M round led by Behigh Investment and KB Investment.

Apollon Filings

Explore SEC and related filing metadata, where available.

Apollon filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Apollon's valuation, stock price, and market status.

Is Apollon a public or private company?

Apollon is a private company.

What is the current stock price of Apollon?

Apollon is a private company, so its shares have no public market price. Caplight tracks Apollon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Apollon worth (valuation)?

Valuation information for Apollon is not publicly available.

Can I buy Apollon stock?

Apollon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Apollon's last funding round?

Apollon's most recent funding round was Seed on April 19, 2024.

Who are the main investors in Apollon?

Key investors in Apollon include KB Investment, KB Investment, Behigh Investment, Mirae Science and Technology Holdings, STIC Ventures.

Will Apollon IPO soon?

No public IPO plans have been announced for Apollon.

How can I track Apollon secondary market activity?

Caplight tracks bids, offers, and trades in Apollon's shares on secondary markets.

Firmographic Details

HeadquartersSeoul
Employee Range43
Year Founded2021
Last FundingApr 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?